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GeauxDock: A Novel Approach for Mixed-Resolution
Ligand Docking Using a Descriptor-Based Force Field
Yun Ding,[a] Ye Fang,[b,c] Wei P. Feinstein,[d] Jagannathan Ramanujam,[b,c]
David M. Koppelman,[b] Juana Moreno,[a,c] Michal Brylinski,*[c,d] and Mark Jarrell*[a,c]
Molecular docking is an important component of computer-
aided drug discovery. In this communication, we describe
GeauxDock, a new docking approach that builds on the ideas
of ligand homology modeling. GeauxDock features a
descriptor-based scoring function integrating evolutionary con-
straints with physics-based energy terms, a mixed-resolution
molecular representation of protein-ligand complexes, and an
efficient Monte Carlo sampling protocol. To drive docking sim-
ulations toward experimental conformations, the scoring func-
tion was carefully optimized to produce a correlation between
the total pseudoenergy and the native-likeness of binding
poses. Indeed, benchmarking calculations demonstrate that
GeauxDock has a strong capacity to identify near-native con-
formations across docking trajectories with the area under
receiver operating characteristics of 0.85. By excluding closely
related templates, we show that GeauxDock maintains its
accuracy at lower levels of homology through the increased
contribution from physics-based energy terms compensating





Computational identification of potential leads against a spe-
cific protein target is of paramount importance to modern
drug design. As of April 2015, the ZINC database of commer-
cially available small molecule entities for drug discovery con-
tains 17,900,742 drug-like compounds collected from the
catalogs of 236 vendors.[1] At the outset of drug development,
this vast number of compounds must be downsized to typi-
cally hundreds to thousands of the most promising candidate
molecules. High-throughput screening (HTS) often adopted by
the pharmaceutical industry is a conventional approach for
lead identification, however, it suffers from high costs and low
hit rates. Conversely, computational methods such as virtual
screening (VS) provide faster and cheaper alternatives to HTS
with many successful examples described in the literature.[2–4]
Current VS techniques fall into two main categories: ligand-
based similarity searching and structure-based molecular dock-
ing.[5] Although the experimentally solved structures of target
proteins are not required in the ligand-based approach, an ini-
tial set of already developed compounds must be known.
However, this information is often unavailable, particularly for
novel molecular targets. In contrast, the advances in X-ray
crystallography and nuclear magnetic resonance result in the
accumulation of atomic-level structures of biological molecules
fostering docking-based drug discovery projects.[6,7]
A typical molecular docking program incorporates two
important components, the prediction of the binding mode of
a drug candidate within the target pocket and the estimation
of binding affinity from molecular interactions. Most currently
available docking approaches implement effective algorithms
to predict near-native binding modes,[8–11] however, noticeable
differences still exist when compared with the experimental
data. For instance, a recent study evaluated seven popular
docking programs on a dataset of 1300 complexes showing a
wide range of the average root-mean-square-deviation (RMSD)
values from 2.7 Å up to 4.5 Å.[12] In addition to binding mode
prediction, a scoring function is another pivotal component of
molecular docking that guides the exploration of the confor-
mational space and estimates the binding affinity for putative
binding modes. Many scoring functions developed to
date[13–18] can be broadly categorized into three classes, force
field-based, empirical, and knowledge-based.[19–21] Recently,
Liu and Wang proposed a new type of scoring function called
descriptor-based or machine learning-based to capture the
new trend in this field.[22] Methods using descriptor-based
scoring functions encode the properties of ligands and
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proteins as well as protein-ligand interactions into sets of
descriptors followed by applying machine learning to compute
protein-ligand binding scores.[22] Notwithstanding the progress
in the development of scoring functions for ligand docking,
several comparative studies reported that no single algorithm
systematically outperforms other methods across all protein
targets.[8,23,24]
In general, high-resolution protein structures are required
for satisfactory results from molecular docking regardless of
which scoring function is used.[25] Additionally, the prediction
success rate drops from the ligand-bound to ligand-free con-
formational state of a target protein.[26] This is due to the fact
that many proteins undergo structural changes in functionally
relevant regions on ligand binding.[27] It has been demon-
strated that even minor changes affect the docking accuracy;
for example, the mean protein rearrangement greater than 1.5
Å may cause a loss of 90% of the initial docking accuracy.[28]
Although high-resolution structures are usually preferred in
docking simulations, these may not be available in the near
future for many pharmacologically important drug targets
such as membrane spanning G-protein coupled receptors and
ion channels.[29] Conversely, Skolnick et al. pointed out that
high-resolution structures may actually conceal the inherent
structural plasticity of ligand binding regions.[30] For instance,
the structural variation of a highly conserved ATP-binding site
is about 2.4 Å, as measured over a subset of inhibitor-bound
crystal structures of protein kinases.[31] To address this issue, a
recently developed ligand homology modeling (LHM)
approach[32] integrates structural information extracted from
evolutionarily related proteins into the modeling of protein-
ligand interactions to improve the tolerance to distortions in
target binding sites. LHM was one of the first approaches to
successfully incorporate evolutionary information in ligand
docking and VS.[30,33] Q-DockLHM[34] further exploited the ideas
of LHM by implementing a descriptor-based scoring function.
Nevertheless, an open question is how evolutionary descrip-
tors supplement physics-based components in a force field
that combines these two classes of scoring terms.
In this study, we describe the development and benchmark-
ing of GeauxDock, a new approach for ligand molecular dock-
ing. GeauxDock uses a descriptor-based scoring function
integrating evolutionary constraints with statistical potentials
and physics-based energy terms. Moreover, it features a
mixed-resolution molecular representation of protein-ligand
complex structures at the level of ligand heavy atoms and pro-
tein effective points. A Monte Carlo protocol is used to effi-
ciently sample the conformational space with the flexibility of
ligand and receptor molecules modeled using an ensemble-
based approach. The scoring function in GeauxDock was para-
meterized on a large dataset of protein-ligand complexes and
further optimized to produce a correlation between the total
pseudoenergy and the native-likeness of binding poses. Finally,
we carry out an analysis of the contribution of various scoring
terms to the identification of final docking conformations. We
demonstrate that although evolutionary constraints generally
improve the docking accuracy, the scarcity of this information
can be effectively compensated by increasing the contribution
from physics-based energy components.
Materials and Methods
Datasets
Two datasets of protein-ligand complexes are used in this
study. The first set was compiled from the eFindSite library[35]
by clustering template proteins at 40% sequence identity
using PISCES[36] and then selecting representative chains that
noncovalently bind small organic molecules at distinct loca-
tions. This procedure resulted in 14,059 nonredundant struc-
tures of protein-ligand complexes, referred to as the eFindSite/
Protein Data Bank (PDB)[37] dataset, that are used to derive
potentials and parameters for the docking force field. The sec-
ond dataset comprises 201 high-quality crystal structures taken
from the Astex/CCDC collection of pharmacologically relevant
drug targets complexed with ligand molecules.[38] As our force
field includes potentials calculated from evolutionarily related
binding pockets, we selected those proteins for which eFind-
Site predicted the binding site within a distance of 8 Å from
the geometric center of a ligand in the experimental complex
structure. eFindSite is a threading/structure-based method that
detects conserved binding sites across sets of homologous
proteins.[35] For each target, we ran eFindSite at two different
thresholds for the maximum target-template sequence iden-
tity, 80 and 40%. The first protocol uses both close and remote
homologs to detect functional sites, whereas the second uses
only those templates that are evolutionarily weakly related to
the target. The Astex/CCDC dataset is used for the force field
optimization and benchmarking.
Molecular representation of complex structures
Docking systems are described using a mixed-resolution
molecular representation; heavy atoms are used for ligands,
whereas proteins are represented at the coarse-grained subre-
sidual level.[39] The following SYBYL chemical types[40] are used
for ligand atoms: carbon (C.1, C.2, C.3, C.ar, and C.cat), nitrogen
(N.1, N.2, N.3, N.4, N.am, N.ar, and N.pl3), oxygen (O.2, O.3, and
O.co2), phosphorous (P.3), sulfur (S.2, S.3, S.O, and S.O2), and
halogens (Br, Cl, F, I). For proteins, two effective backbone
points per residue are placed at the position of its Ca atom
and the geometrical center of the peptide plane (PP). Small
side chains of Ala, Asn, Asp, Cys, Ile, Leu, Pro, Ser, Thr, and Val
are reduced to one pseudo atom located at the geometric
center (e.g., Ala-1, Asn-1, etc.), whereas longer side chains of
Arg, Gln, Glu, His, Lys, Met, Phe, Trp, and Tyr are described by
two effective points corresponding to the middle of a virtual
bond between Cb and Cc atoms (e.g., Arg-1, Gln-1, etc.), and
the geometric center of the remaining side-chain atoms (e.g.,
Arg-2, Gln-2, etc.). Such a low-resolution description of pro-
teins has been shown to improve the tolerance to deforma-
tions in the target structures, while maintaining reasonable
details of the physicochemical features of amino acids.[34]
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Protein-ligand contacts
Intermolecular contacts between ligand atoms and protein
effective points are calculated using type-dependent distance
thresholds, Dcntlp , that accurately reproduce high-resolution
interatomic contacts.[41] In addition to several contact-based
components of the docking force field, mixed-resolution pro-
tein-ligand contacts are used to quantify the similarity between
binding modes. Specifically, we use a Contact Mode Score (CMS)
that calculates Matthew’s correlation coefficient between two
sets of intermolecular contacts derived from a pair of ligand
binding modes for a given protein-ligand system:
CMS5
TP3TN2FP3FNffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TP1FPð Þ TP1FNð Þ TN1FPð Þ TN1FNð Þ
p (1)
where TP is the number of true positives, that is, interatomic
contacts that are correctly predicted, and TN is the number of
true negatives, that is, those pairs of ligand atoms and protein
effective points that are correctly predicted not to be in con-
tact. FP and FN are the numbers of false positives and false
negatives, respectively, that is, those contacts that are overpre-
dicted and underpredicted. Theoretically, CMS ranges from 21
to 1 with higher values indicating a better overlap between the
two sets of contacts. In practice, because ligand conformations
are confined to the vicinity of a protein pocket, CMS varies
from about 0 up to 1. It also has certain advantages over other
similarity measures. In contrast to the RMSD, CMS is fairly inde-
pendent of the ligand size, therefore, it provides a more intui-
tive metric for the analysis of datasets comprising different
compounds and target proteins. Finally, compared with the frac-
tion of overlapping contacts, CMS penalizes those contacts that
are overpredicted and underpredicted in docking models.
Force field for molecular docking
Protein-ligand complexes are stabilized by a variety of molecu-
lar interactions. Here, we developed a new descriptor-based
force field for the modeling of protein-ligand interactions that
combines classical physics-based potentials with statistical and
knowledge-based scoring terms. Specifically, we include the
following nine energy terms: (i) electrostatic and (ii) van der
Waals interactions, (iii) hydrogen bonds, (iv) hydrophobic inter-
actions, (v) generic and (vi) pocket-specific contact potentials,
(vii) a pseudopharmacophore potential, and position restraints
on (viii) family conserved anchor substructures, and (ix) the
binding site center.
Electrostatic and van der Waals interactions (i, ii). Because of
the mixed-resolution model, we use soft electrostatic, Psoftele , and
soft Lennard-Jones, PsoftvdW , potentials.
[42] Electrostatic interac-
tions are described by:
Psoftele l; pð Þ5qlqpg rlp
 
(2)
Let rlp be the distance between the lth ligand atom and the
pth protein effective point with the corresponding partial
charges ql and qp. Then g rlp
 





lp for Rlp < 1, where Rlp5srlp, a5423k and b52k23.
k is an adjustable parameter that controls the value of the elec-
trostatic potential at zero separation and it is set to 2.0, and s is
a scaling factor set to 0.5. Partial charges on ligand atoms are
calculated using the Mulliken population analysis[43] imple-
mented in Open Babel,[44] whereas those on protein effective
points are assigned by adding partial charges from the constitu-
ent atoms according to the Assisted Model Building with
Energy Refinement (AMBER) ff03ua force field.[45]
The electrostatic interaction score, Esoftele , is a sum of P
soft
ele val-
ues taken over L 3 P pairs of ligand atoms and protein effec-








Psoftele l; pð Þ (3)
Van der Waals interactions are modeled using the following
form of a soft Lennard-Jones potential:

















where rlp depends on both a ligand atom type and the amino
acid effective point and it is defined as rlp5jD
cnt
lp . E is the
depth of the potential well, and rlp is the distance between
the lth ligand atom and the pth protein point. The parameter
a controls the value of the function at rlp50, and the parame-
ter b controls the rate at which the function approaches the
maximum value at zero separation.
Type-dependent parameters E are derived from the eFind-






where nlp is the observed number of contacts between a
given pair of a ligand atom type and the amino acid effective
point, and n0lp is an expected number of contacts assuming no
specificity. The latter is defined as n0lp5Nvlvp, with the total
number of N protein-ligand contacts, and vl and vp corre-
sponding to the mole fractions of ligand atoms of type l and
protein points of type p, respectively.
Parameters a, b; and j are optimized empirically on the





PnatvdW l; pð Þ2hPdecvdW l; pð Þi
d
(6)
where the summation runs over D pairs of ligand atoms and
protein points that are in contact according to the mixed-
resolution models of dataset complexes. PnatvdW is the value of
the soft Lennard-Jones potential, PsoftvdW , for a given pair of the
lth ligand atom and the pth protein point. hPdecvdW l; pð Þi is the
value of PsoftvdW averaged over a set of 10 “decoy” distances rlp
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randomly generated around the interaction threshold Dcntlp , and
d is the corresponding standard deviation. The optimal values
of a50:88, b50:74, and j50:70 were found using the evolu-
tionary search strategy.[46]
For a given protein-ligand complex, the van der Waals inter-
action score, EsoftvdW , is calculated by summing P
soft
vdW values over
all ligand atoms and protein effective points, and then normal-








PsoftvdW l; pð Þ (7)
Hydrogen bonds (iii). The hydrogen bond potential, PHB, only
applies to those atom pairs that can form hydrogen bonds
and it is modeled using single Gaussian restraints:









where rHBlp is the distance between the lth ligand atom and
the pth protein effective point, and lHBlp is the average hydro-
gen bond length between ligand atoms of the same type as l
and protein points of the same type as p across the eFindSite/
PDB dataset, with the corresponding standard deviation rHBlp .
For a given protein-ligand complex, its hydrogen bond score
is calculated by summing PHB over those pairs of ligand atoms
and protein effective points that can form hydrogen bonds,












Hydrophobic interactions (iv). Hydrophobic interactions
between ligand atoms and protein effective points are mod-
eled using a spatial hydrophobicity distribution and softened
Gaussian restraints. First, we calculate an empirical hydropho-
bicity, PHP lð Þ, at the position of a ligand atom l resulting from
the surrounding P protein side chains within a distance of rmax




















where rlp is the distance between the lth ligand atom and the
pth protein effective point, rmax has a fixed value of 9 Å,
[47]
and klp5rlp=rmax. ~Hp is the hydrophobicity parameter for the
pth protein effective point according to a scale derived for
amino acids in globular proteins from crystallographic data.[48]
Next, we calculate a natural logarithm of the common Gaus-
sian restraint with the average hydrophobicity lHPl and the cor-
















Ligand type-dependent parameters lHPl andr
HP
l are derived
from the eFindSite/PDB dataset by calculating the average
empirical hydrophobicity, PHP lð Þ, and the corresponding stand-
ard deviation for different ligand atom types.
The hydrophobic interaction score, EHP, is taken as the aver-






PrestHP lð Þ (12)
Generic and pocket-specific contact potentials (v, vi). The
molecular docking force field implemented in GeauxDock also
includes generic and pocket-specific contact potentials. The
generic potential, PCP, between the lth ligand atom and the
pth protein effective point is calculated as follows:







where nlp is the observed number of contacts between ligand
atoms of a similar type as l and protein effective points of a
similar type as p across the eFindSite/PDB dataset, and n0lp is a
reference number of contacts assuming no specificity
[explained in eq. (5)]. S rlp
 










 h i (14)
where rlp is the distance between l and p, and D
cnt
lp is the con-
tact threshold that depends on the types of both l and p.
The generic contact score, ECP, is calculated by summing PCP
values over all pairs of ligand atoms and protein effective points,








PCP l; pð Þ (15)
In addition to the generic potential PCP derived from the
eFindSite/PDB dataset, we calculate PPSCP, a pocket-specific (PS)
contact potential.[34] The PS version uses the same formalism as
the generic potential, however, rather than derived from the
eFindSite/PDB, the numbers of contacts nlp and n
0
lp are calculated
using a set of evolutionarily related complex structures identified
for a given target protein by eThread[49] and eFindSite.[35] Similar
to ECP, the pocket-specific contact score, E
PS








PPSCP l; pð Þ (16)
Family conserved anchor substructures and pseudopharmaco-
phore potential (vii, viii). Ligands extracted from evolutionarily
related complex structures are also used to impose a series of
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harmonic restraints on family conserved anchor substructures,
which were shown to be highly effective in ligand docking,[50]
and to construct a new pseudopharmacophore model. The for-
mer performs the chemical matching of a target ligand against all
template ligands using kcombu[51] to identify the maximum com-
mon substructures (MCS). Subsequently, atomic equivalences
within MCS provided by kcombu are used to calculate a weighted
average for RMSD values obtained against a set of A template
ligands, with weights corresponding to the target-template chem-
ical similarity measured by the Tanimoto coefficient.[52] A position
restraint, PMCS, imposed on the ath anchor substructure, which is










where the summation runs over E pairs of equivalent atoms in
the target and template ligands sharing the ath anchor sub-
structure, and rea is the atomic distance for the eth pair.
Typically, multiple templates and the corresponding anchor
substructures are detected for a given protein-ligand target,
therefore, the final score taking into account family conserved
anchor substructures, EMCS, is calculated as the natural loga-









where TCa is the Tanomoto coefficient corresponding to the
chemical similarity between the ath template ligand and the
target molecule, and A is the total number of templates used
to extract the anchor substructures.
The second energy term in this group uses a pseudophar-
macophore potential. Specifically, it applies a Kernel Density
Estimation (KDE) method to the positions of heavy atoms of
template ligands bound to the identified homologs to esti-
mate a probability density function. We use a standard normal
density function to describe the likelihood of an atom of the
docking ligand to be at a certain position within the binding
site; the following is the scaled form of the kernel, Kh:








where h is the bandwidth with a value of 0.5, l is a target
ligand atom, and e is a template ligand atom (l and e are of
the same type). KDE provides a convenient way of data
smoothing, where inferences about the population are made
based on a finite data sample.[53,54]
The pseudopharmacophore potential on the lth ligand atom










where E is the total number of template ligands.
The pseudopharmacophore score for a given configuration
of a ligand within the binding site of the target protein is cal-






PPHR lð Þ (21)
Distance restraint (ix). Finally, to limit the search space to the
vicinity of a binding site, the following distance constraint is
imposed:
EDST5rcen (22)
where rcen is the distance between the ligand geometric center
and the binding pocket center predicted by eFindSite.[35]
Ensemble docking
The flexibility of ligands and proteins in molecular docking is
implemented using an ensemble-based approach. This com-
monly used technique first precalculates an ensemble of low-
energy conformations and then performs a rigid-body docking
for each conformer.[55,56] For ligands, we used a procedure
described previously[50] to generate nonredundant ensembles
comprising up to 50 low-energy conformations whose pairwise
RMSD is >1 Å. Protein ensembles were constructed using Mod-
eller[57] based on the experimental structure of each target (self-
modeling). We used only the coordinates of Ca atoms belong-
ing to nonbinding residues to fully explore the flexibility of
ligand binding regions. For each target protein, 10 models were
generated by Modeller through three rounds of optimization
using a variable target function method and molecular dynam-
ics refinement with the objective function set to 106.
Monte Carlo sampling
We use the Metropolis Monte Carlo (MMC) method[34,58] to
sample the conformational space of protein-ligand interac-
tions. This space consists of multiple subspaces representing
unique combinations of protein and ligand conformations
from the precalculated ensembles. In the current implementa-
tion, each subspace is sampled independently using the MMC
method and the collected trajectories are merged at the end
of simulations. In each single MMC step, the position and ori-
entation of a ligand are randomly perturbed by translational
and rotational steps about the x, y, and z-axis of up to 0.02 Å
and 5 deg, respectively. We found that this protocol allows a
ligand to freely explore the conformation space without com-
promising the precision. Furthermore, the temperature factor
is chosen such that the average acceptance ratio is about 0.5.
Note that in GeauxDock, both the perturbation scale and the
temperature factor can be modified to achieve a better per-
formance for particular systems. As MMC simulations search
for the global minimum energy state of a system, a scoring
function implemented in GeauxDock is optimized to assign
low pseudoenergy values to near-native conformations. Conse-
quently, native-like binding modes are frequently visited
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during the conformational sampling providing a sufficient
resolution of biologically relevant states.
Force field optimization
The total pseudoenergy score for a given configuration of a
ligand within the binding site of its protein target is calculated










The energy weight factors, w1–w9, are optimized on a large
and nonredundant set of protein-ligand conformations con-
structed for the Astex/CCDC dataset.[59] Specifically, for each
complex, we first generated 105 configurations through a series
of MMC simulations including only the Lennard-Jones potential
(i) to prevent steric clashes and the distance constraint (ix) to
confine the sampling to the vicinity of a binding pocket. Next,
we calculated pairwise CMS values for all conformations to cre-
ate a 105 3 105 CMS matrix. To remove redundancy, this matrix
was subjected to clustering using CLUTO[60] resulting in 5000
groups; a cluster centroid was selected to represent each group.
The final dataset comprises 102,000 nonredundant protein-
ligand configurations constructed for 204 complexes.
Subsequently, we compiled two subsets for the force field
optimization, a group of 36,022 native-like conformations
whose CMS values calculated against the experimental com-
plex structures are 0.6, and a set of 847,849 decoys with the
CMS of 0.4. The native-like recognition capability of the scor-
ing function was enhanced by finding the set of weights w1–
w9 [see eq. (23)] that maximize the energy gap between







where hEni and hEdi are the mean energy values calculated for
native-like and decoy conformations, respectively, with the cor-
responding standard deviations rn and rd .
We used the evolutionary search algorithm[46] emulating the
principles of natural evolution to identify the optimal set of
energy weight factors that maximize the Z-score. To avoid any
bias, the optimization was performed 10 times starting from
different initial random sets of weights; the final weight factors
were taken as the consensus of the 10 optimization rounds.
Other scoring functions
Two state-of-the-art algorithms, DrugScoreX (DSX)[14] and
Ligand-Protein Contacts (LPC),[61] were selected for comparative
benchmarks of GeauxDock. DSX is a knowledge-based scoring
function that features a distance-dependent pair potential, a
torsion angle potential, and a novel solvent accessible surface-
dependent potential.[14] LPC uses a scoring function that evalu-
ates the geometric and chemical complementarity between a
ligand and its receptor protein.[62] Both programs were used
with their default set of parameters.
Results and Discussion
Ensembles for pseudoflexible docking
It is well known that both proteins and ligands often undergo
structural changes on complex formation[27,63–65]; for instance,
an analysis of 27 flexible ligands shows the RMSD variation
from 0.19 to 2.96 Å[65] calculated between single-crystal and
protein-bound states. A larger structural diversity is expected
as the size of ligand molecules increases; for instance, the con-
formational range for two ubiquitous compounds, nicotina-
mide adenine dinucleotide and flavin adenine dinucleotide
was calculated as 3.58 Å 6 0.08 and 3.49 Å 6 0.13, respectively,
when bound to proteins.[64] On that account, an accurate rep-
resentation of biomolecules in simulations requires sampling
multiple conformational states.[66] We use an ensemble dock-
ing technique to handle this issue in a discrete manner. Specif-
ically, conformers are selected from a precomputed pool of
configurations covering a large conformational space that
includes biologically relevant molecules. In that regard, we
investigate the coverage of Astex/CCDC ligands by calculating
Figure 1. Structural characteristics of protein and ligand ensembles for
pseudoflexible docking. All-atom RMSD values are calculated using the
native conformation for a) ligands and b) protein binding sites. Dashed
lines point out the estimated ranges of the molecular plasticity. Blue,
green, and red lines correspond to the maximum, minimum, and median
RMSD within each ensemble; molecules are sorted on the x-axis by their
median values.
FULL PAPER WWW.C-CHEM.ORG
2018 Journal of Computational Chemistry 2015, 36, 2013–2026 WWW.CHEMISTRYVIEWS.COM
RMSD values using conformational ensembles and the corre-
sponding experimental structures. The results in terms of maxi-
mum, minimum, and median RMSD values are presented in
Figure 1. Figure 1a shows that the median RMSD for 81% of
the flexible ligands is within the reference range of 0.19 to
2.96 Å[65] suggesting that the ligand flexibility is well repre-
sented across the generated docking ensembles. Furthermore,
the average plasticity of ligand-binding regions in proteins
expressed as the mean RMSD was estimated as 2.6 Å with a
standard deviation of 1.0 Å.[67] Protein ensembles constructed
in this study fall within this range with the median binding
site RMSD calculated over 204 ensembles of 2.61 Å, as shown
in Figure 1b. Collectively, these results demonstrate that con-
formational ensembles for pseudoflexible docking provide a
sufficient coverage of biologically relevant structures of both
ligands and their protein targets.
Force field parameterization
Force fields for molecular modeling typically require a careful
parameterization to reproduce experimental data. We derived
the parameters for GeauxDock from the eFindSite/PDB dataset,
a representative and nonredundant collection of protein-
ligand complex structures. Selected force field potentials para-
meterized against eFindSite/PDB are presented in Figure 2. Fig-
ure 2a shows the soft Lennard-Jones potential used to model
van der Waals interactions between effective points on Phe
and Arg side chains, and selected ligand atoms. The corre-
sponding parameters E that define the depth of the potential
well are reported in Table 1. For instance, aromatic interactions
between Phe-2 and C.ar, and a salt bridge between Arg-2 and
O.co2 have deeper potential wells with E51:95 and E51:54,
respectively, compared to those less favorable, for example,
Phe-2 and N.3 E51:07ð Þ, and Arg-2 and N.am E50:43ð Þ. Fur-
thermore, the softened potential, which is weaker at short dis-
tances than the traditional form, is more appropriate to model
interactions involving effective points representing clouds of
atoms rather than the hard spheres of individual particles.
We also use a soft version of the electrostatic potential,
where its values do not extend to infinity when the interaction
distance r approaches zero. As shown in Figure 2b, the electro-
static potential creates a repulsion at close distances between
Figure 2. Examples of selected force field potentials. a) Type-dependent soft Lennard-Jones potential, b) soft electrostatic potential between protein effec-
tive points and various charges on ligand atoms q, c) hydrogen bond restraints, d) restraints for hydrophobic interactions between different ligand atoms
as a function of local hydrophobicity, e) extreme values for the log-odds potential between aromatic carbon C.ar and protein effective points, f ) generic
contact potential including a smoothing function, and g) probability density for different ligand atoms estimated by KDE along the x-axis.
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those groups whose partial charges have the same sign,
whereas positively and negatively charged particles attract
each other. The strength of these interactions depends on the
partial charges on individual groups. Table 2 lists net charges
assigned to protein effective points by collapsing AMBER par-
tial charges of the constituent atoms. A point charge on the
PP has a fixed value of 20.246, which balances positively
charged Ca atoms of individual amino acids. Side chains of
small hydrophobic residues are slightly positively charged, for
example, qp50:047 for Ile-1, in contrast to small polar amino
acids that carry small negative charges on their side chains, for
example, qp520:046 for Ser-1. A small negatively charged Asp
has the unit charge assigned to its side chain effective point,
whereas larger charged residues have almost unit charge val-
ues; for example, the parameter qp is 20.792, 0.901, and 0.927
for Glu-2, Arg-2, and Lys-2, respectively. Partial charges on
ligand heavy atoms are calculated for individual compounds
using the Mulliken population analysis,[43] which is a widely
used parameterization method in molecular docking.
Hydrogen bonds are modeled for hydrogen donor-acceptor
pairs using single Gaussian restraints. Table 3 lists force field
parameters for hydrogen bonds and Figure 2c shows the para-
meterized potential for selected pairs. Mean values for the
interaction distance, lHBlp , derived from the eFindSite/PDB data-
set, give the optimal type-dependent bond lengths, whereas
rHBlp parameters that describe the deviation from average inter-
action distances across the dataset, control the interaction
strength. For instance, lHBlp for Thr-1 and N.3 (3.59 Å) is slightly
smaller than that for Tyr-2 and N.am (3.88 Å). Moreover, the
corresponding rHBlp are 0.95 and 0.78, respectively, thus, the
strength of hydrogen bonded pair of Tyr-2 and N.am at the
optimal distance is greater than a hydrogen bond between
Thr-1 and N.3.
In our model, protein residues create a polar/hydrophobic
local environment favoring certain types of ligand atoms.
These hydrophobic interactions are parameterized using statis-
tics collected for eFindSite/PDB protein-ligand complexes and
a standard hydrophobicity scale for amino acids. The derived
force field parameters reported in Table 4 are in good agree-
ment with physicochemical properties of ligand atom types.





tend toward nonpolar residues, whereas amine
nitrogen lHPl 520:27
 
and carboxylate oxygen lHPl 520:34
 





C.3 C.ar C.cat N.3 N.am N.ar O.2 O.3 O.co2 P.3 S.3 S.O2 Cl
Ca e 0.59 0.65 0.99 0.53 0.44 0.86 1.08 0.86 0.95 0.05 0.62 0.82 1.03
PCP 0.21 0.09 20.47 0.37 0.59 20.33 20.69 20.26 20.47 3.01 0.15 20.19 20.63
PP e 0.66 0.79 0.87 0.64 0.56 0.61 0.83 0.58 1.02 0.05 0.84 0.80 1.05
PCP 0.10 20.09 20.20 0.13 0.32 0.22 20.23 0.14 20.55 20.69 20.25 20.14 20.57
Phe-1 e 0.63 0.77 1.30 0.64 0.30 0.63 0.75 0.43 0.55 0.26 0.79 0.30 1.07
PCP 0.12 20.10 20.96 0.10 1.22 20.10 20.13 0.56 0.37 4.01 20.18 0.87 20.67
Phe-2 e 1.77 1.95 1.58 1.07 1.34 1.95 1.46 1.29 1.60 1.17 1.66 0.82 2.19
PCP 21.55 21.79 21.33 20.69 21.10 21.72 21.21 21.00 21.27 20.86 21.48 20.26 22.11
Arg-1 e 0.19 0.21 0.12 0.47 0.18 0.26 0.39 0.31 0.52 0.43 0.25 0.05 0.25
PCP 1.60 1.40 2.06 0.53 1.61 1.17 0.85 1.18 0.36 0.63 1.10 3.00 1.29
Arg-2 e 0.63 0.55 0.27 0.70 0.43 0.62 1.00 0.82 1.54 0.00 1.08 0.85 0.56
PCP 0.09 0.29 1.07 20.01 0.63 0.14 20.58 20.31 21.31 6.52 20.80 0.04 0.29
[a]e is the depth of the potential well in the softened Lennard-Jones potential; PCP is the value of contact potential for pairwise interactions.





Gly 0.246 – –
Ala 0.215 0.031 –
Asn 0.217 0.029 –
Asp 0.246 21.000 –
Cys 0.088 0.158 –
Ile 0.199 0.047 –
Leu 0.204 0.042 –
Pro 0.112 0.119 –
Ser 0.292 20.046 –
Thr 0.268 20.022 –
Val 0.201 0.045 –
Arg 0.237 0.107 0.901
Glu 0.246 20.208 20.792
Gln 0.210 0.010 0.026
His 0.219 0.172 20.145
Lys 0.227 0.092 0.927
Met 0.137 0.127 20.018
Phe 0.214 0.049 20.017
Trp 0.248 0.066 20.068
Tyr 0.245 0.020 20.020
Table 3. Force field parameters for hydrogen bonds, lHBlp 6 r
HB
lp , for





His-2 Ser-2 Thr-1 Tyr-2 PP
N.2 3.38 6 0.71 3.83 6 0.83 3.91 6 0.99 3.64 6 0.77 3.91 6 0.88
N.3 3.67 6 0.71 3.80 6 0.88 3.59 6 0.95 3.79 6 0.89 3.89 6 0.92
N.am 3.80 6 0.75 3.82 6 0.83 3.79 6 0.82 3.88 6 0.78 3.62 6 0.82
O.2 3.58 6 0.78 3.64 6 0.87 3.62 6 0.86 3.75 6 0.92 3.69 6 0.84
O.3 3.64 6 0.83 3.68 6 0.86 3.72 6 0.85 3.74 6 0.85 3.85 6 0.84
O.co2 3.50 6 0.76 3.45 6 0.87 3.64 6 0.92 3.46 6 0.86 3.75 6 0.86
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atoms prefer a polar microenvironment. Hydrophobicity
restraints PrestHP for selected ligand atom types are shown in Fig-
ure 2d as a function of the environment created by surround-
ing amino acids. The extremes of 21.0 and 1.0 describe a
strongly polar and nonpolar character, respectively. The posi-
tion of the function minimum determines the optimal environ-
ment for a particular atom type described by PHP, thus, Cl and
C.ar are on the positive side, and N.am and O.3 are on the
negative side of the protein hydrophobicity range.
Statistical potentials are commonly used components of
molecular docking force fields.[41,68–70] In this study, the param-
eters for pairwise interactions between ligand heavy atoms
and protein effective points were derived from the eFindSite/
PDB dataset. The log-odds potential expresses the likelihood
of individual contacts, where the interactions averaged over
the entire dataset are taken as a reference state. Figure 2e
shows the extreme values for the contact potential between
aromatic carbon C.ar and all types of protein effective points.
Clearly, aromatic moieties on the side chain effective points of
Phe-2, Trp-2, and Tyr-2, as well as the hydrophobic parts of
Cys-1, Ile-1, Met-2, Leu-1, and Val-1 make contacts with C.ar
more often than by a random chance. In contrast, the polar
and charged groups of Glu-1, Lys-1, Arg-1, Glu-1, Glu-2, and
Lys-2 are statistically unlikely to interact with ligand aromatic
carbon atoms. Moreover, backbone effective points Ca and PP
have no distinct preferences toward interacting with C.ar.
In the GeauxDock force field, we use a smoothing function
that is less sensitive to small changes in ligand coordinates at
the contact distance thresholds than the commonly used step
function. This is shown in Figure 2f for selected interactions
between ligand heavy atoms and protein effective points. For
instance, salt bridges between Arg-2 and O.co2, and Asp-1
and N.3 contribute half of their negative interaction energy at
Dcntlp 55:76 Å and D
cnt
lp 55:36 Å, respectively. Similarly, the posi-
tive energy contributions from destabilizing interactions
between Ala-1 and O.3, and Glu-2 and C.ar reach half of their
values at the corresponding contact thresholds. In addition to
the generic contact potential derived from the eFindSite/PDB
dataset, we calculate its pocket-specific variant using evolutio-
narily related complexes identified by sequence profile-based
protein threading. These potentials are specific toward a par-
ticular family of proteins, however, they contain significantly
less parameters compared with the generic potential because
of much smaller sample sizes (the number of template com-
plexes). For example, out of 720 pairwise parameters derived
from the eFindSite/PDB dataset for PCP, the average number of
PPSCP parameters calculated across the Astex/CCDC target pock-
ets is only 110 6 67. Nonetheless, the latter have been demon-
strated to be more accurate than the generic potential in the
scoring and ranking of ligand binding modes.[34]
Different from traditional pharmacophore-based models that
use known bio-actives to calculate sets of steric and physico-
chemical features necessary for molecular recognition,[71] the
pseudopharmacophore potential in GeauxDock is derived from
evolutionarily ligand-bound templates. Specifically, it estimates
a probability for each ligand heavy atom type to be at a cer-
tain position within the binding site. For instance, Figure 2g
shows a one-dimensional probability density for C.ar, N.am,
O.co2, and O.3 along the x-coordinate with the pocket cen-
tered at x5y5z50 Å (the full potential is the product of prob-
abilities at x, y, and z coordinates). In this example, amine
nitrogen and hydroxyl oxygen atoms are most likely to be
found at x5-1:4 Å and x5-2:5 Å, respectively. Carboxyl oxy-
gen atoms have a bimodal distribution typical for symmetric
moieties with two equivalent peaks at x50:4 Å and x52:5 Å,
whereas aromatic carbon atoms have a relatively broad proba-
bility of occurrence at -0:6 < x < 2:5 Å. Favoring ligand heavy
atoms at their high probability positions predicts binding
modes consistent with the conserved evolutionary profiles
observed across sets of homologous proteins.
Force field optimization
Force field weights were optimized on a large dataset of
protein-ligand configurations generated for Astex/CCDC com-
plexes using the evolutionary search algorithm. The objective
was to maximize the Z-score corresponding to the energy gap
between native-like and decoy conformations. Figure 3a shows
the trajectory of Z-score in one complete optimization process.
The simulation converges within 400 generations, indicating
an efficient update of weight factors. We performed the total
of 10 simulations seeded with random initial weight factors;
each calculation resulted in the same set of weight factors
w1518:97; w250:78;ð w352:05; w450:53; w550:01;
w650:53; w750:88; w85110:82; and w9546:4Þ, suggest-
ing that the optimized values are stable and robust. Figures
3b and 3c show the distribution of energy values with differ-
ent sets of weights. In Figure 3b, random weight factors do
not provide a clear separation between native-like (green dots)
and decoy (red dots) conformations whose median energy
score is 21.67 and 21.03, respectively. In contrast, Figure 3c
shows that the optimized weight factors yield better energy-
based partitioning of native-like and decoy conformations;
here, native-like (decoy) binding modes have a median energy
of 20.16 (0.58). This analysis suggests that the total pseudoe-
nergy calculated using the optimized set of weights has a
Table 4. Force field parameters for hydrophobic interactions, lHPl 6 r
HP
l ,
assigned to selected ligand types.
Ligand atom type lHPl 6 r
HP
l
C.3 20.03 6 0.43
C.ar 0.11 6 0.46
C.cat 20.26 6 0.43
N.3 20.27 6 0.44
N.am 20.10 6 0.38
N.ar 0.03 6 0.47
O.2 20.21 6 0.50
O.3 20.28 6 0.46
O.co2 20.34 6 0.46
P.3 20.50 6 0.41
S.3 20.14 6 0.45
S.O2 20.10 6 0.40
Cl 0.24 6 0.52
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great potential to effectively drive molecular docking toward
correct ligand binding modes.
Recognition of native-like conformations
A strong capacity to identify native-like binding modes among
a vast number of generated configurations plays a pivotal role
in successful ligand docking simulations. Therefore, in Figure 4,
we conduct a comparative Receiver Operating Characteristics
(ROC) analysis of GeauxDock and two other scoring functions,
DSX[14] and LPC.[61] Here, we use a precompiled dataset of
protein-ligand configurations comprising 36,022 native-like
binding poses and 847,849 decoys generated for Astex/CCDC
complexes to uniformly cover the conformational space. In
general, all docking algorithms are capable of identifying cor-
rect conformations across the training MMC trajectories gener-
ated for the Astex/CCDC dataset better than a purely random
guess (dashed line). The area under the curve (AUC) for the
unoptimized GeauxDock force field (all weight factors set to
1.0) is 0.654 in contrast to 0.851 for the optimized set of
weights. For comparison, DSX_pair, DSX_pair_sas and LPC yield
the AUC of 0.847, 0.858, and 0.765, respectively. Despite a
slightly lower AUC, GeauxDock gives 5% higher true positive
rate than DSX_pair_sas at relatively small false positive rates of
0.1–0.2. The results for DSX consistent with the original bench-
marking calculations[24] suggest that our dataset is of high
quality and the CMS indeed provides an effective evaluation
metric.
Next, we performed full docking calculations using Geaux-
Dock. The major difference from the previous analysis is that
these validation simulations start from a random ligand con-
formation and use the complete, optimized force field to
guide the conformational sampling. MMC trajectories gener-
ated for the Astex/CCDC dataset are analyzed in Figure 5. First,
for each benchmarking complex, we calculated the Z-score
between native-like and decoy conformations extracted from
the docking trajectories. As shown in Figure 5a, 90% of the
cases have positive Z-score values indicating that ligand bind-
ing modes close to native are systematically assigned a lower
energy than those farther away from the experimental confor-
mation. The median Z-score across Astex/CCDC complexes is
1.0, which is in accord with the training results reported in
Figure 3. To further evaluate the quality of the GeauxDock
force field, we calculated the Pearson correlation coefficient
(PCC) between the total pseudoenergy score and CMS. Figure
5b shows that in the majority of the cases, the total pseudoe-
nergy score and CMS are negatively correlated, that is, the
energy increases with the decreasing similarity to the experi-
mental binding mode. According to the scale provided
by Salkind,[72] a very strong 21:0  PCC < 20:8ð Þ, strong
20:8  PCC < 20:6ð Þ, moderate 20:6  PCC < 20:4ð Þ, weak
20:4  PCC < 20:2ð Þ, and very weak or no correlation
Figure 3. Force field optimization using the evolutionary algorithm. a) The trajectory of Z-score in the course of the optimization procedure. The distribu-
tion of pseudoenergy values for native-like (green) and decoy (red) conformations for the b) unoptimized and c) optimized force field. Boxes in b and c
end at the quartiles Q1 and Q3, a horizontal blue line in a box is the median, and whiskers show the 1.5 interquartile range. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
Figure 4. Recognition of native-like conformations across docking trajecto-
ries. A ROC plot for GeauxDock with an optimized force field is compared
with those obtained using the unoptimized force field as well as other
scoring functions, DSX and LPC. TPR – true positive rate, FPR – false posi-
tive rate. [Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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-0:2  PCC < 0:0ð Þ between energy and CMS was obtained for
3.43%, 15.20%, 28.43%, 25.49%, and 14.22% of the Astex/
CCDC complexes, respectively; only 13.24% of the cases give
the undesired positive correlation. Altogether, these results
demonstrate that the scoring function in GeauxDock is cor-
rectly optimized to drive MMC simulations toward experimen-
tally determined ligand binding modes.
Case studies
We select a couple of examples to demonstrate the accuracy
of GeauxDock in finding near-native ligand binding modes,
cathepsin K complexed with a peptidomimetic inhibitor (PDB-
ID: 1bgo, chain A),[73] and actinidin complexed with an inhibi-
tor E-64 (PDB-ID: 1aec, chain A).[74] Both compounds were
docked into the active sites of their target protein using
GeauxDock starting from a random initial conformation. The
results are shown in Figure 6 (panels a–c for cathepsin K and
d-f for actinidin). First, we plot the values of CMS calculated
against inhibitors bound in the crystal complex structures, and
the total pseudoenergy, E, extracted from MMC trajectories. A
high pseudoenergy and a low CMS for initial configurations
indicate that ligands are far away from their native states (Fig-
ures 6a and 6d). During MMC simulations, a gradually decreas-
ing energy E guides the conformational sampling to the
vicinity of the experimental binding modes of inhibitors as
indicated by high CMS values at the end of simulations. Fig-
ures 6b and 6e demonstrate that in both cases, the optimized
Figure 5. Quality assessment for the optimized force field implemented in GeauxDock. Histograms of a) Z-score and b) the PCC calculated from the Monte
Carlo trajectories collected for the Astex/CCDC dataset.
Figure 6. Docking results for a–c) cathepsin K and d–f ) actinidin from GeauxDock. a, d) Monte Carlo trajectories for the Contact Mode Score (CMS) and the
pseudoenergy, b, e) scatter plots of the CMS versus pseudoenergy, c, f ) representative conformations taken from docking trajectories. In b, c, e, and f
selected non-native, intermediate, and near-native conformations are colored in red, orange, and green, respectively, whereas the experimental binding
poses are shown in ice blue. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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force field yields a negative correlation between CMS and E,
where each dot represents one MMC snapshot. Next, we select
three representative conformations from those scatter plots for
each inhibitor, non-native (red), intermediate (orange), and
near-native (green), whose CMS are 0.38, 0.49, and 0.90 for
cathepsin K, and 0.38, 0.49, and 0.86 for actinidin, respectively.
The corresponding molecular representations are shown in
Figures 6c and 6f using the same color scheme. In both cases,
low-energy binding modes (green) significantly overlap with
bound inhibitors in the experimental structures of cathepsin K
and actinidin complexes (ice blue sticks), whereas non-native
and intermediate conformations are characterized by notably
higher pseudoenergy values.
Evolution- and physics-based components
A descriptor-based force field in GeauxDock combines evolu-
tion- and physics-based scoring terms. The former are derived
from evolutionary related complex structures at two different
sequence similarity thresholds, 80% to allow force field param-
eters to be calculated from close homologs, and 40% to use
only those templates that are weakly related to their targets.
Therefore, we can analyze how the level of homology affects
the accuracy of molecular docking. Using the Astex/CCDC
dataset, the results are reported in Table 5 as the area under
the ROC curve. As expected, the AUC significantly increases
when close homologs are included in force field optimization
and the docking conformations are evaluated by evolution-
based components alone. In contrast, the performance of
physics-based scoring terms remains, to a large extent, unaf-
fected by the maximum target-template sequence identity,
because these features are calculated from physical interac-
tions that are more universal.[75] Interestingly, the performance
of GeauxDock using a complete force field at a homology
threshold of 80% is only slightly better than that at 40%, sug-
gesting that the descriptor-based scoring function is able to
adapt to the supplied amount of evolutionary information to
maintain its accuracy.
To further investigate this intriguing observation, we calcu-
lated the relative contribution of both classes of scoring terms
to the total pseudoenergy at the two homology thresholds.
Figure 7 shows that the contribution from evolution-based
components to the total score is about 5% higher at 80%
homology compared with 40%. Considering only a slightly
better performance of GeauxDock using close homologs, this
analysis suggests that the scarcity of evolutionary information
can be effectively compensated by the increased contribution
from physics-based scoring terms. This unique feature of
GeauxDock is particularly important in its large-scale applica-
tions at the proteome level, such as in inverse VS[76,77] and
rational drug repositioning,[78–80] where the availability of only
weakly homologous complex structures for the majority of
drug targets will not compromise the accuracy of molecular
docking.
A well-balanced contribution of physics- and evolution-
based energy terms to the total pseudoenergy also suggests
that these two classes of scoring features effectively comple-
ment each other. Nevertheless, AUC values reported in Table 5
indicate that a linear combination of individual energy terms
perhaps does not fully exploit their predictive power; for
instance, adding the evolution-based component improves the
AUC of physics-based terms by about 3%. This may be caused
by the feature intercorrelation, which is known to limit the
performance improvements despite adding more descrip-
tors.[81] A possible solution is to combine individual energy
terms using a nonlinear model, under the assumption that
noncovalent interactions often depend on one another in a
nonlinear manner.[82] We will explore the feasibility of a
machine learning-based force field in ligand molecular docking
in the near future.
Conclusions
In this study, we describe the development of GeauxDock, a
molecular docking approach featuring a novel descriptor-
based scoring function and a mixed-resolution description of
protein-ligand complexes. The scoring function was parameter-
ized on a large dataset of crystal structures and further opti-
mized using sets of computer-generated native-like and decoy
conformations. Encouragingly, benchmarking calculations dem-
onstrate that GeauxDock has a strong capacity to recognize
native-like binding modes with the area under ROC of 0.85.
The descriptor-based scoring function implemented in Geaux-
Dock incorporates two distinct classes of energy terms,
Table 5. Performance of GeauxDock on the Astex/CCDC dataset assessed
by the area under the curve (AUC).
Scoring function
AUC




The force field is optimized at the homology thresholds of 40 and 80%
and the performance of the complete scoring function is compared
with physics- and evolution-based components.
Figure 7. Balance of various energy terms in the optimized force field. The
contribution from physics- and evolution-based components is calculated
at the thresholds of 80 and 40% for the maximum target-template
sequence identity.
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physics- and evolution-based. As the latter are derived from
evolutionary related complex structures, their strength
depends on the level of homology between the target and
template systems. Interestingly, weak evolutionary constraints
are effectively compensated by the increased contribution
from physics-based terms, which, in turn, help maintain the
accuracy of the GeauxDock scoring function at the lower levels
of protein sequence similarity. Therefore, this new ligand dock-
ing approach is well suited for proteome-scale applications
taking advantage of the increasingly growing protein
sequence and structural data. GeauxDock is available at http://
www.institute.loni.org/lasigma/package/dock/.
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